gemfibrozil has been researched along with dabrafenib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aktan, G; Arkenau, HT; Blackman, SC; Botbyl, J; Carson, SW; Gordon, MS; Grossmann, KF; Infante, JR; Kendra, K; LoRusso, PM; Middleton, MR; Ouellet, D; Pant, S; Patel, M; Richards-Peterson, LE; Sharma, S; Suttle, AB | 1 |
1 trial(s) available for gemfibrozil and dabrafenib
Article | Year |
---|---|
Assessment of the drug interaction potential and single- and repeat-dose pharmacokinetics of the BRAF inhibitor dabrafenib.
Topics: Anticoagulants; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Gemfibrozil; Humans; Imidazoles; Ketoconazole; Male; Middle Aged; Oximes; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Warfarin | 2015 |